Showing results (1641-1650 of 3,386) with videos related to
Sort By:
Pageof 339
Molecular Pharmaceutics|May 28, 2020
PTML Model for Selection of Nanoparticles, Anticancer Drugs, and Vitamins in the Design of Drug-Vitamin Nanoparticle Release Systems for Cancer CotherapyRicardo Santana, Robin Zuluaga, Piedad Gañán, et al.Plos One|March 7, 2025
Hypertension associated with serotonin reuptake inhibitors: A new analysis in the WHO pharmacovigilance database and examination of dose-dependencyBasile Chrétien, Andry Rabiaza, Nishida Kazuki, et al.Scientific Reports|December 17, 2023
MarrowCellDLD: a microfluidic method for label-free retrieval of fragile bone marrow-derived cellsGloria Porro, Rita Sarkis, Clara Obergozo, et al.Plos Genetics|October 9, 2024
Surface exclusion of IncC conjugative plasmids and their relativesNicolas Rivard, Malika Humbert, Kévin T Huguet, et al.Applied and Environmental Microbiology|May 5, 2005
Combined antimicrobial resistance in Enterococcus faecium isolated from chickensOdile Petsaris, Fabien Miszczak, Mireille Gicquel-Bruneau, et al.The EMBO Journal|June 1, 2010
Prp43p contains a processive helicase structural architecture with a specific regulatory domainHélène Walbott, Saïda Mouffok, Régine Capeyrou, et al.Journal of Clinical Medicine|April 3, 2021
Characteristics of Adult Patients with Idiopathic Retroperitoneal Fibrosis and Assessment of Risk of Relapse at DiagnosisJerome Razanamahery, Bastien Bouldoires, Sebastien Humbert, et al.The European Respiratory Journal|December 1, 2006
Pulmonary artery distensibility in pulmonary arterial hypertension: an MRI pilot studyC Jardim, C E Rochitte, M Humbert, et al.European Journal of Drug Metabolism and Pharmacokinetics|July 1, 1985
Cross-over study of the pharmacokinetics of cefonicid administered intravenously or intramuscularly to healthy adult humansJ B Fourtillan, A Leroy, M A Lefebvre, et al.Digestive Diseases and Sciences|November 26, 1999
Serological markers and HLA-DQ2 haplotype among first-degree relatives of celiac patients. Catalonian Coeliac Disease Study GroupC Farré, P Humbert, P Vilar, et al.Pageof 339